Shielding the First 24 Postnatal Months of Life: A Proposal for a Prospective Cohort Study of Early-Life Electromagnetic Exposure and Autism Risk

Abstract

Background: Autism Spectrum Disorder (ASD) involves Mirror Neuron System (MNS) dysfunction, driving core social and imitative impairments. Systemic physiological alterations such as autonomic dysregulation, mitochondrial dysfunction and neuroinflammation are known to impair synchronization and plasticity of neuronal clusters. A less-evident environmental cofactor, coinciding with rising ASD prevalence, is the considerable world-wide increase in electromagnetic radiation (EMR) overall exposure among children. Experimental evidence shows how low-intensity EMR influences cellular processes, via voltage-gated calcium channels (VGCCs), oxidative stress, and mitochondrial metabolism. The Resonant Convergence framework, allow to predict how chronic EMR exposure during the first 24 postnatal months of life can act as a factor in ASD pathogenesis. The best candidate mechanism is chronic Ion Cyclotron Resonance (ICR) detuning the Ca2+-calmodulin pathway, thus disrupting MNS synchronization. Methods and Analysis: A prospective observational pilot cohort study (24-month follow-up) proposes to enroll 1000 full-term newborns into two arms: an EMR-reduced cohort (n = 500, rest and sleep-phase Faraday shielding) and a standard exposure cohort (n = 500). Exposure is quantified via radiofrequency (RF)/extremely low frequency(ELF) measurements, proximity analysis, device inventories and wearable dosimetry. The primary endpoint is a continuous neurodevelopmental trajectory score (joint attention, language, electroencephalogram (EEG) mu-rhythm); binary ASD diagnosis (Autism Diagnostic Observation Schedule, Second Edition (ADOS-2), Autism Diagnostic Interview-Revised (ADI-R)) is a secondary, exploratory endpoint. Moreover, an optional genomic screening will evaluate gene-environment interactions within extremely low-frequency electromagnetic field (ELF-EMF) vulnerable pathways, including ASD-associated genes upregulated by RF via bromodomain and extraterminal protein (BET)-mediated epigenetic mechanisms. Analyses will employ risk ratios, Fisher’s exact tests and logistic regression adjusted for confounders; mixed-effects and Bayesian modeling will evaluate longitudinal outcomes and exposure reduction effects. Given a 2–3% baseline prevalence, approximately 20–30 ASD cases are expected. The study is therefore powered for exploratory signal detection rather than definitive causal inference, providing the critical baseline data required to justify and design future confirmatory trials. Sex-stratified modeling will address the 4:1 male-to-female prevalence ratio. Ethics and Dissemination: Ethics committee approval is not yet sought; full protocol review and approval will be obtained prior to the study initiation, in strict accordance with the Declaration of Helsinki. Written parental informed consent will be mandatory for all participants prior to enrollment. Study findings and methodological milestones will be disseminated through peer-reviewed international scientific publications. This protocol provides a structured methodological framework for the first prospective investigation of sleep-phase EMR reduction as a potential modulator of ASD incidence during early neurodevelopment. Results will inform adequately powered confirmatory trials in electromagnetic neurodevelopmental epidemiology.

AI evidence extraction

Main findings

This is a proposed prospective pilot cohort study; no participants have been enrolled and no results are reported. The planned comparison is between 500 infants receiving rest- and sleep-phase EMR shielding and 500 infants with standard exposure.

Outcomes measured

• Neurodevelopmental trajectory score incorporating joint attention, language, and EEG mu-rhythm
• ASD diagnosis (secondary, exploratory endpoint)

Limitations

• Study has not begun, and ethics approval has not yet been sought.
• Approximately 20–30 ASD cases are expected, so the study is intended for exploratory signal detection rather than definitive causal inference.
• The proposed observational design requires adjustment for confounders.

{
    "study_type": "cohort",
    "exposure": {
        "band": "RF and ELF",
        "source": null,
        "frequency_mhz": null,
        "sar_wkg": null,
        "duration": "Planned 24-month follow-up from birth; reduced exposure during rest and sleep"
    },
    "population": "Full-term newborns",
    "sample_size": 1000,
    "outcomes": [
        "Neurodevelopmental trajectory score incorporating joint attention, language, and EEG mu-rhythm",
        "ASD diagnosis (secondary, exploratory endpoint)"
    ],
    "main_findings": "This is a proposed prospective pilot cohort study; no participants have been enrolled and no results are reported. The planned comparison is between 500 infants receiving rest- and sleep-phase EMR shielding and 500 infants with standard exposure.",
    "effect_direction": "unclear",
    "limitations": [
        "Study has not begun, and ethics approval has not yet been sought.",
        "Approximately 20–30 ASD cases are expected, so the study is intended for exploratory signal detection rather than definitive causal inference.",
        "The proposed observational design requires adjustment for confounders."
    ],
    "evidence_strength": "insufficient",
    "confidence": 0.9699999999999999733546474089962430298328399658203125,
    "peer_reviewed_likely": "unknown",
    "keywords": [
        "electromagnetic exposure",
        "radiofrequency",
        "extremely low frequency",
        "autism spectrum disorder",
        "early-life exposure",
        "prospective cohort protocol",
        "Faraday shielding",
        "neurodevelopment"
    ],
    "suggested_hubs": []
}

Comments

Log in to comment.

No comments yet.